Ionis is a leading brand in the field of genetic medicines, focused on the discovery, development, and delivery of life-transforming treatments. They are dedicated to transforming the standard of care and pioneering new markets in healthcare. With a strong executive and leadership team, Ionis is committed to being a force for life.

Their innovative approach is based on antisense technology, which allows for targeted gene therapy and has led to a promising pipeline of potential treatments. Ionis also supports scientific innovation through their Ion-ARPA Initiative, providing grants and sponsorships to further advance genetic medicine. Ionis prioritizes patients and the community, offering clinical trials, patient resources, and community engagement programs.

They strive to improve patient experiences and provide access to cutting-edge therapies. Investors and media can find comprehensive information on Ionis, including newsroom updates, press releases, financial reports, and stock information. Ionis is known for its strong governance practices and investor resources.

For those interested in a career at Ionis, they offer a dynamic and inclusive work environment, with opportunities for growth and development. Employee spotlight features and volunteerism show their commitment to impacting lives beyond the clinic. Follow Ionis on Twitter and Facebook to stay updated on their latest developments in the field of genetic medicines.

With Ionis, every moment matters in the quest to transform lives through innovative genetic therapies